Nuclear compartmentalization of N-CoR and its interactions with steroid receptors

Molecular and Cellular Biology

Volumn 26, Issue 17, 2006, Pages 6633-6655

  Wu, Yin ^a   Kawate, Hisaya ^a   Ohnaka, Keizo ^a   Nawata, Hajime ^a   Takayanagi, Ryoichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMANITIN; ANDROGEN RECEPTOR; ANDROSTANOLONE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DACTINOMYCIN; ESTROGEN RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR ALPHA; GREEN FLUORESCENT PROTEIN; NUCLEAR RECEPTOR COREPRESSOR; REPRESSOR PROTEIN; STEROID RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; YELLOW FLUORESCENT PROTEIN;

AGONIST; ANIMAL CELL; ARTICLE; BLEACHING; CELL COMPARTMENTALIZATION; CELL NUCLEUS; COMPLEX FORMATION; CONTROLLED STUDY; DNA TRANSCRIPTION; DOSE RESPONSE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR COMPARTMENTALIZATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RECEPTOR BINDING; RECEPTOR OCCUPANCY; TRANSACTIVATION; TRANSCRIPTION INITIATION;

3T3-L1 CELLS; ANIMALS; CELL COMPARTMENTATION; CELL LINE, TUMOR; CELL NUCLEUS STRUCTURES; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; CREB-BINDING PROTEIN; DIHYDROTESTOSTERONE; GREEN FLUORESCENT PROTEINS; HISTONE ACETYLTRANSFERASES; HUMANS; LIGANDS; MICE; MUTANT PROTEINS; NIH 3T3 CELLS; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, ANDROGEN; RECEPTORS, STEROID; REPRESSOR PROTEINS; RNA SPLICING; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 33748121414     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01534-05     Document Type: Article

References (68)

1. Agoulnik I. U., W. C. Krause, W. E. Bingman III, H. T. Rahman, M. Amrikachi, G. E. Ayala, and N. L. Weigel. 2003. Repressors of androgen and progesterone receptor action. J. Biol. Chem. 278:31136-31148.
2. Alen, P., F. Claessens, G. Verhoeven, W. Rombauts, and B. Peeters. 1999. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol. Cell. Biol. 19:6085-6097.
3. Ariumi, Y., T. Ego, A. Kaida, M. Matsumoto, P. P. Pandolfi, and K. Shimotohno. 2003. Distinct nuclear body components, PML and SMRT, regulate the trans-acting function of HTLV-1 Tax oncoprotein. Oncogene 22:1611-1619.
4. Barrack, E. R. 1987. Specific association of androgen receptors and estrogen receptors with the nuclear matrix: summary and perspectives, p. 85-107. In V. K. Moudgil (ed.), Recent advances in steroid hormone action. Walter de Gruijter, Berlin, Germany.
5. Beato, M., and J. Klug. 2000. Steroid hormone receptors: an update. Hum. Reprod. Update 6:25-36.
6. Belmont, A. 2003. Dynamics of chromatin, proteins, and bodies within the cell nucleus. Curr. Opin. Cell Biol. 15:304-310.
7. Bubulya, A., S. Y. Chen, C. J. Fisher, Z. Zheng, X. Q. Shen, and L. Shemshedini. 2001. c-Jun potentiates the functional interaction between the amino and carboxyl termini of the androgen receptor. J. Biol. Chem. 276:44704-44711.
8. Chen, J. D., K. Umesono, and R. M. Evans. 1996. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc. Natl. Acad. Sci. USA 93:7567-7571.
9. Cheng, S., S. Brzostek, S. R. Lee, A. N. Hollenberg, and S. P. Balk. 2002. Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor. Mol. Endocrinol. 16:1492-1501.
10. Dotzlaw, H., U. Moehren, S. Mink, A. C. Cato, J. A. Iniguez Lluhi, and A. Baniahmad. 2002. The amino terminus of the human AR is target for corepressor action and antihormone agonism. Mol. Endocrinol. 16:661-673.
11. Downes, M., P. Ordentlich, H. Y. Kao, J. G. Alvarez, and R. M. Evans. 2000. Identification of a nuclear domain with deacetylase activity. Proc. Natl. Acad. Sci. USA 97:10330-10335.
12. Fan, W., T. Yanase, Y. Wu, H. Kawate, M. Saitoh, K. Oba, M. Nomura, T. Okabe, K. Goto, J. Yanagisawa, S. Kato, R. Takayanagi, and H. Nawata. 2004. Protein kinase A potentiates adrenal 4 binding protein/steroidogenic factor 1 transactivation by reintegrating the subcellular dynamic interactions of the nuclear receptor with its cofactors, general control nonderepressed-5/ transformation/transcription domain-associated protein, and suppressor, dosage-sensitive sex reversal-1: a laser confocal imaging study in living KGN cells. Mol. Endocrinol. 18:127-141.
13. Fejes-Tóth, G., D. Pearce, and A. Náray-Fejes-Tóth. 1998. Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists. Proc. Natl. Acad. Sci. USA 95:2973-2978.
14. Graham, J. D., D. L. Bain, J. K. Richer, T. A. Jackson, L. Tung, and K. B. Horwitz. 2000. Nuclear receptor conformation, coregulators, and tamoxifen-resistant breast cancer. Steroids 65:579-584.
15. Hager, G. L., A. K. Nagaich, T. A. Johnson, D. A. Walker, and S. John. 2004. Dynamics of nuclear receptor movement and transcription. Biochim. Biophys. Acta 1677:46-51.
16. Hager, G. L., C. Elbi, and M. Becker. 2002. Protein dynamics in the nuclear compartment. Curr. Opin. Genet. Dev. 12:137-141.
17. Hager, G. L. 1999. Studying nuclear receptors with green fluorescent protein fusions. Methods Enzymol. 302:73-84.
18. He, B., and E. M. Wilson. 2002. The NH(2)-terminal and carboxyl-terminal interaction in the human androgen receptor. Mol. Genet. Metab. 75:293-298.
19. Heltweg, B., and M. Jung. 2002. A microplate reader-based nonisotopic histone deacetylase activity assay. Anal. Biochem. 302:175-183.
20. Hodgson, M. C., I. Astapova, S. Cheng, L. J. Lee, M. C. Verhoeven, E. Choi, S. P. Balk, and A. N. Hollenberg. 2005. The androgen receptor recruits nuclear receptor corepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists. J. Biol. Chem. 280:6511-6519.
21. Horlein, A. J., A. M. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C. K. Glass, and M. G. Rosenfeld. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404.
22. Htun, H., L. T. Holth, D. Walker, J. R. Davie, and G. L. Hager. 1999. Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor. Mol. Biol. Cell 10:471-486.
23. Hu, X., Y. Li, and M. A. Lazar. 2001. Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors. Mol. Cell. Biol. 21:1747-1758.
24. Ikonen, T., J. J. Palvimo, and O. A. Janne. 1997. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J. Biol. Chem. 272:29821-29828.
25. Ishizuka, M., H. Kawate, R. Takayanagi, H. Ohshima, R. H. Tao, and H. Hagiwara. 2005. A zinc finger protein TZF is a novel corepressor of androgen receptor. Biochem. Biophys. Res. Commun. 331:1025-1031.
26. Jackson, T. A., J. K. Richer, D. L. Bain, G. S. Takimoto, L. Tung, and K. B. Horwitz. 1997. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol. Endocrinol. 11:693-705.
27. Jenster, G., H. A. van der Korput, J. Trapman, and A. O. Brinkmann. 1995. Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J. Biol. Chem. 270:7341-7346.
28. Jones, P. L., and Y. B. Shi. 2003. N-CoR-HDAC corepressor complexes: roles in transcriptional regulation by nuclear hormone receptors. Curr. Top. Microbiol. Immunol. 274:237-268.
29. Kawata, M. 2001. Subcellular steroid/nuclear receptor dynamics. Arch. Histol. Cytol. 64:353-368.
30. Kawate, H., Y. Wu, K. Ohnaka, H. Nawata, and R. Takayanagi. 2005. Tob proteins suppress steroid hormone receptor-mediated transcriptional activation. Mol. Cell. Endocrinol. 230:77-86.
31. Langley, E., Z. X. Zhou, and E. M. Wilson. 1995. Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J. Biol. Chem. 270:29983-29990.
32. Li, J., J. Fu, C. Toumazou, H. G. Yoon, and J. Wong. 2006. A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin. Mol. Endocrinol. 20:776-785.
33. Liao, G., L. Y. Chen, A. Zhang, A. Godavarthy, F. Xia, J. C. Ghosh, H. Li, and J. D. Chen. 2003. Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT. J. Biol. Chem. 278:5052-5061.
34. McNally, J. G., W. G. Müller, D. Walker, R. Wolford, and G. L. Hager. 2000. The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science 287:1262-1265.
35. Metivier, R., G. Penot, M. R. Hubner, G. Reid, H. Brand, M. Kos, and F. Gannon. 2003. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751-763.
36. Moilanen, A., N. Rouleau, T. Ikonen, J. J. Palvimo, and O. A. Janne. 1997. The presence of a transcription activation function in the hormone-binding domain of androgen receptor is revealed by studies in yeast cells. FEBS Lett. 412:355-358.
37. Nagy, L., H. Y. Kao, D. Chakravarti, R. J. Lin, C. A. Hassig, D. E. Ayer, S. L. Schreiber, and R. M. Evans. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380.
38. Nagy, L., H. Y. Kao, J. D. Love, C. Li, E. Banayo, J. T. Gooch, V. Krishna, K. Chatterjee, R. M. Evans, and J. W. Schwabe. 1999. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 13:3209-3216.
39. Perissi, V., A. Aggarwal, C. K. Glass, D. W. Rose, and M. G. Rosenfeld. 2004. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116:511-526.
40. Phair, R. D., and T. Misteli. 2000. High mobility of proteins in the mammalian cell nucleus. Nature 404:604-609.
41. Saitoh, M., R. Takayanagi, K. Goto, A. Fukamizu, A. Tomura, T. Yanase, and H. Nawata. 2002. The presence of both the amino- and carboxyl-terminal domains in the AR is essential for the completion of a transcriptionally active form with coactivators and intranuclear compartmentalization common to the steroid hormone receptors: a three-dimensional imaging study. Mol. Endocrinol. 16:694-706.
42. Schaaf, M. J., and J. A. Cidlowski. 2003. Molecular determinants of glucocorticoid receptor mobility in living cells: the importance of ligand affinity. Mol. Cell. Biol. 23:1922-1934.
43. Schaaf, M. J., L. J. Lewis-Tuffin, and J. A. Cidlowski. 2005. Ligand-selective targeting of the glucocorticoid receptor to nuclear subdomains is associated with decreased receptor mobility. Mol. Endocrinol. 19:1501-1515.
44. Schulz, M., M. Eggert, A. Baniahmad, A. Dostert, T. Heinzel, and R. Renkawitz. 2002. RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding. J. Biol. Chem. 277:26238-26243.
45. Smith C. L., Z. Nawaz, and B. W. O'Malley. 1997. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol. Endocrinol. 11:657-666.
46. Söderström, M., A. Vo, T. Heinzel, R. M. Lavinsky, W. M. Yang, E. Seto, D. A. Peterson, M. G. Rosenfeld, and C. K. Glass. 1997. Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes. Mol. Endocrinol. 11:682-692.
47. Stein, G. S., S. K. Zaidi, C. D. Braastad, M. Montecino, A. J. van Wijnen, J. Y. Choi, J. L. Stein, J. B. Lian, and A. Javed. 2003. Functional architecture of the nucleus: organizing the regulatory machinery for gene expression, replication and repair. Trends Cell Biol. 13:584-592.
48. Stenoien, D. L., K. Patel, M. G. Mancini, M. Dutertre, C. L. Smith, B. W. O'Malley, and M. A. Mancini. 2001. FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent. Nat. Cell Biol. 3:15-23.
49. Stenoien, D. L., M. G. Mancini, K. Patel, E. A. Allegretto, C. L. Smith, and M. A. Mancini. 2000. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1. Mol. Endocrinol. 14:518-534.
50. Stenoien, D. L., M. Mielke, and M. A. Mancini. 2002. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components. Nat. Cell Biol. 4:806-810.
51. Szapary, D., Y. Huang, and S. S. Simons, Jr. 1999. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression. Mol. Endocrinol. 13:2108-2121.
52. Tao, R. H., H. Kawate, Y. Wu, K. Ohnaka, M. Ishizuka, A. Inoue, H. Hagiwara, and R. Takayanagi. 2006. Testicular zinc finger protein recruits histone deacetylase 2 and suppresses the transactivation function and intranuclear foci formation of agonist-bound androgen receptor competitively with TIF2. Mol. Cell. Endocrinol. 247:150-165.
53. Tazawa, H., W. Osman, Y. Shoji, E. Treuter, J. A. Gustafsson, and J. Zilliacus. 2003. Regulation of subnuclear localization is associated with a mechanism for nuclear receptor corepression by RIP140. Mol. Cell. Biol. 23:4187-4198.
54. Tetel, M. J., S. Jung, P. Carbajo, T. Ladtkow, D. F. Skafar, and D. P. Edwards. 1997. Hinge and amino-terminal sequences contribute to solution dimerization of human progesterone receptor. Mol. Endocrinol. 11:1114-1128.
55. Tian, B., Z. Mei, Y. Song, J. Dian, Y. Dong, H. Liu, B. Liu, G. Zhao, and Z. Sun. 2006. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7. J. Cell. Biochem. 97:561-571.
56. Tomura, A., K. Goto, H. Morinaga, M. Nomura, T. Okabe, T. Yanase, R. Takayanagi, and H. Nawata. 2001. The subnuclear three-dimensional image analysis of androgen receptor fused to green fluorescence protein. J. Biol. Chem. 276:28395-283401.
57. Tsai M. J., and B. W. O'Malley. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:451-486.
58. Voss, T. C., I. A. Demarco, C. F. Booker, and R. N. Day. 2005. Corepressor subnuclear organization is regulated by estrogen receptor via a mechanism that requires the DNA-binding domain. Mol. Cell. Endocrinol. 231:33-47.
59. Voss, T. C., I. A. Demarco, C. F. Booker, and R. N. Day. 2005. Functional interactions with Pit-1 reorganize corepressor complexes in the living cell nucleus. J. Cell Sci. 118:3277-3288.
60. Wang, D., and S. S. Simons, Jr. 2005. Corepressor binding to progesterone and glucocorticoid receptors involves the activation function-1 domain and is inhibited by molybdate. Mol. Endocrinol. 19:1483-1500.
61. Wang, Q., J. A. Blackford, Jr., L. N. Song, Y. Huang, S. Cho, and S. S. Simons, Jr. 2004. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors. Mol. Endocrinol. 18:1376-1395.
62. Warnmark, A., E. Treuter, A. P. Wright, and J. A. Gustafsson. 2003. Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Mol. Endocrinol. 17:1901-1909.
63. Webb, P., C. M. Anderson, C. Valentine, P. Nguyen, A. Marimuthu, B. L. West, J. D. Baxter, and P. J. Kushner. 2000. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol. Endocrinol. 14:1976-1985.
64. Wu, X., H. Li, E. J. Park, and J. D. Chen. 2001. SMRTe inhibits MEF2C transcriptional activation by targeting HDAC4 and 5 to nuclear domains. J. Biol. Chem. 276:24177-24185.
65. Yeh, S., E. R. Sampson, D. K. Lee, E. Kim, C. L. Hsu, Y. L. Chen, H. C. Chang, S. Altuwaijri, K. E. Huang, and C. Chang. 2000. Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer. J. Formos. Med. Assoc. 99:885-894.
66. Yoon, H. G., D. W. Chan, Z. Q. Huang, J. Li, J. D. Fondell, J. Qin, and J. Wong. 2003. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J. 22:1336-1346.
67. Zeng, C., E. Kim, S. L. Warren, and S. M. Berget. 1997. Dynamic relocation of transcription and splicing factors dependent upon transcriptional activity. EMBO J. 16:1401-1412.
68. Zhao, Y., K. Goto, M. Saitoh, T. Yanase, M. Nomura, T. Okabe, R. Takayanagi, and H. Nawata. 2002. Activation function-1 domain of androgen receptor contributes to the interaction between subnuclear splicing factor compartment and nuclear receptor compartment. Identification of the p102 U5 small nuclear ribonucleoprotein particle-binding protein as a coactivator for the receptor. J. Biol. Chem. 277:30031-30039.